MedPath

sodium oxybate

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 2002

Approved
Approval ID

bcef2c95-35e9-464d-9025-652acff769e7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 25, 2023

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 080189610

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium oxybate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0054-9628
Application NumberNDA021196
Product Classification
M
Marketing Category
C73605
G
Generic Name
sodium oxybate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 4, 2022
FDA Product Classification

INGREDIENTS (1)

SODIUM OXYBATEActive
Quantity: .5 g in 1 mL
Code: 7G33012534
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

sodium oxybate - FDA Drug Approval Details